Vcanbio Cell & Gene Engineering Corp., Ltd

XSSC:600645 Stock Report

Market Cap: CN¥10.0b

Vcanbio Cell & Gene Engineering Future Growth

Future criteria checks 2/6

Vcanbio Cell & Gene Engineering is forecast to grow earnings and revenue by 21.6% and 8.8% per annum respectively. EPS is expected to grow by 22.2% per annum. Return on equity is forecast to be 4.7% in 3 years.

Key information

21.6%

Earnings growth rate

22.2%

EPS growth rate

Biotechs earnings growth38.5%
Revenue growth rate8.8%
Future return on equity4.7%
Analyst coverage

Low

Last updated30 Aug 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

XSSC:600645 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,010200N/A4471
12/31/20251,867171N/A4031
12/31/20241,737147N/A3961
6/30/20241,594109198285N/A
3/31/20241,610109205293N/A
12/31/20231,590106210299N/A
9/30/20231,581131179269N/A
6/30/20231,584131170269N/A
3/31/20231,538115159259N/A
12/31/20221,555113163262N/A
9/30/20221,55279157267N/A
6/30/20221,536109185304N/A
3/31/20221,563146165302N/A
12/31/20211,535155193321N/A
9/30/20211,509-69222325N/A
6/30/20211,467-97192282N/A
3/31/20211,409-87217290N/A
12/31/20201,319-127153244N/A
9/30/20201,3518993236N/A
6/30/20201,33868102233N/A
3/31/20201,34225118240N/A
12/31/20191,38750119241N/A
9/30/20191,355-182128234N/A
6/30/20191,345-18960183N/A
3/31/20191,320-43-5135N/A
12/31/20181,321592130N/A
9/30/20181,333317-2783N/A
6/30/20181,32732268165N/A
3/31/20181,434116N/A141N/A
12/31/20171,32110N/A104N/A
9/30/20171,23860N/A127N/A
6/30/20171,11322N/A46N/A
3/31/201787672N/A128N/A
12/31/201683838N/A144N/A
9/30/2016768130N/A85N/A
6/30/2016740-64N/A37N/A
3/31/201672141N/A-17N/A
12/31/2015709208N/A8N/A
9/30/201567669N/A134N/A
6/30/2015615305N/A197N/A
3/31/2015544188N/A203N/A
12/31/201447735N/A221N/A
9/30/201440057N/A154N/A
6/30/201438929N/A167N/A
3/31/201438323N/A137N/A
12/31/20133617N/A111N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600645's forecast earnings growth (21.6% per year) is above the savings rate (2.9%).

Earnings vs Market: 600645's earnings (21.6% per year) are forecast to grow slower than the CN market (23.2% per year).

High Growth Earnings: 600645's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600645's revenue (8.8% per year) is forecast to grow slower than the CN market (13.2% per year).

High Growth Revenue: 600645's revenue (8.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600645's Return on Equity is forecast to be low in 3 years time (4.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y